Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DONEPEZIL for Secondary progressive multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where DONEPEZIL was used for Secondary progressive multiple sclerosis.

Most Reported Side Effects for DONEPEZIL

Side Effect Reports % Deaths Hosp.
Fall 764 8.7% 220 432
Diarrhoea 654 7.4% 190 247
Bradycardia 644 7.3% 19 507
Dizziness 600 6.8% 207 199
Syncope 594 6.7% 161 346
Vomiting 587 6.6% 158 255
Nausea 581 6.6% 158 222
Drug interaction 542 6.1% 115 239
Decreased appetite 478 5.4% 167 119
Confusional state 467 5.3% 25 251
Somnolence 449 5.1% 169 128
Insomnia 378 4.3% 189 79
Malaise 363 4.1% 157 91
Fatigue 362 4.1% 168 70
Headache 341 3.9% 177 25

Other Indications for DONEPEZIL

Product used for unknown indication (2,988) Dementia alzheimer's type (2,313) Dementia (1,350) Cognitive disorder (350) Memory impairment (198) Dementia with lewy bodies (168) Amnesia (85) Mixed dementia (84) Ill-defined disorder (63) Vascular dementia (54)

Other Drugs Used for Secondary progressive multiple sclerosis

SIPONIMOD (2,265) OCRELIZUMAB (1,273) OFATUMUMAB (1,099) FINGOLIMOD (351) INTERFERON BETA-1B (146) RITUXIMAB (131) NATALIZUMAB (115) DIMETHYL (96) INTERFERON BETA-1A (89) RABEPRAZOLE (86)

Related Pages

DONEPEZIL Full Profile All Secondary progressive multiple sclerosis Drugs DONEPEZIL Demographics DONEPEZIL Timeline